Terns Pharmaceuticals Inc. (TERN) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-14
4:51 pm
Purchase
2025-09-3013GTerns Pharmaceuticals, Inc.
TERN
Commodore Capital LP5,700,000
6.500%
1,050,000increase
(+22.58%)
Filing
History
2025-11-05
4:13 pm
Sale
2025-11-0313DTerns Pharmaceuticals, Inc.
TERN
ORBIMED ADVISORS LLC4,240,068
4.800%
-3,322,903decrease
(-43.94%)
Filing
History
2025-10-31
11:31 am
Purchase
2025-09-3013GTerns Pharmaceuticals, Inc.
TERN
The Vanguard Group4,559,917
5.210%
4,559,917increase
(New Position)
Filing
History
2025-09-16
6:00 pm
Purchase
2025-09-0913GTerns Pharmaceuticals, Inc.
TERN
Commodore Capital LP4,650,000
5.300%
4,650,000increase
(New Position)
Filing
History
2025-08-14
08:51 am
Purchase
2025-06-3013GTerns Pharmaceuticals, Inc.
TERN
Deep Track Capital, LP7,495,000
8.580%
1,918,442increase
(+34.40%)
Filing
History
2025-05-15
4:31 pm
Sale
2025-03-3113GTerns Pharmaceuticals, Inc.
TERN
Schonfeld Strategic Advisors LLC4,305,204
4.930%
-929,304decrease
(-17.75%)
Filing
History
2025-05-15
08:47 am
Sale
2025-03-3113GTerns Pharmaceuticals, Inc.
TERN
Deep Track Capital, LP5,576,558
6.390%
-523,442decrease
(-8.58%)
Filing
History
2025-05-07
11:29 am
Purchase
2025-03-3113GTerns Pharmaceuticals, Inc.
TERN
MORGAN STANLEY
MS
7,099,954
8.100%
7,099,954increase
(New Position)
Filing
History
2025-02-14
6:25 pm
Purchase
2024-12-3113GTerns Pharmaceuticals, Inc.
TERN
Citadel Advisors LLC3,465,307
4.100%
54,543increase
(+1.60%)
Filing
History
2025-02-14
4:15 pm
Purchase
2024-12-3113GTerns Pharmaceuticals, Inc.
TERN
Schonfeld Strategic Advisors LLC5,234,508
6.160%
5,234,508increase
(New Position)
Filing
History
2025-02-11
4:00 pm
Purchase
2024-12-3113GTerns Pharmaceuticals, Inc.
TERN
Soleus Capital Master Fund, L.P.8,142,500
9.600%
1,918,956increase
(+30.83%)
Filing
History
2025-02-05
5:28 pm
Purchase
2024-12-3113GTerns Pharmaceuticals, Inc.
TERN
BlackRock Inc.
BLK
5,743,482
6.800%
1,044,711increase
(+22.23%)
Filing
History
2024-11-15
10:35 am
Sale
2024-09-3013GTerns Pharmaceuticals, Inc.
TERN
Point72 Asset Management, L.P.2,894,093
3.500%
-1,027,133decrease
(-26.19%)
Filing
History
2024-11-14
7:00 pm
Purchase
2024-09-3013GTerns Pharmaceuticals, Inc.
TERN
Vivo Capital Fund VIII L.P.4,597,243
5.400%
4,597,243increase
(New Position)
Filing
History
2024-11-14
5:51 pm
Sale
2024-09-3013GTerns Pharmaceuticals, Inc.
TERN
Venrock Healthcare Capital Partners III, L.P.3,516,889
4.990%
-980,228decrease
(-21.80%)
Filing
History
2024-11-14
4:15 pm
Sale
2024-09-3013GTerns Pharmaceuticals, Inc.
TERN
Fairmount Funds Management LLC0
0.000%
-6,632,015decrease
(Position Closed)
Filing
History
2024-11-14
3:41 pm
Sale
2024-09-3013GTerns Pharmaceuticals, Inc.
TERN
SUVRETTA CAPITAL MANAGEMENT LLC0
0.000%
-5,837,126decrease
(Position Closed)
Filing
History
2024-11-14
3:30 pm
Purchase
2024-09-3013GTerns Pharmaceuticals, Inc.
TERN
Soleus Capital Master Fund, L.P.6,223,544
7.300%
2,882,424increase
(+86.27%)
Filing
History
2024-11-08
2:17 pm
Unchanged
2024-09-3013GTerns Pharmaceuticals, Inc.
TERN
BlackRock Inc.
BLK
4,698,771
5.600%
0
(Unchanged)
Filing
History
2024-11-05
4:15 pm
Sale
2024-09-3013GTerns Pharmaceuticals, Inc.
TERN
Integrated Core Strategies (US) LLC1,628,534
1.900%
-1,851,096decrease
(-53.20%)
Filing
History
Goto 0, 1, 2, 3, Next